Estonja - Estonjan - Ravimiamet

sandoz pharmaceuticals d.d. - sunitiniib - kõvakapsel - 25mg 110tk; 25mg 28tk; 25mg 56tk; 25mg 30tk; 25mg 100tk; 25mg 90tk; 25mg 70tk; 25mg 98tk; 25mg 84tk

Estonja - Estonjan - Ravimiamet

sandoz pharmaceuticals d.d. - sunitiniib - kõvakapsel - 50mg 30tk

Estonja - Estonjan - Ravimiamet

sandoz pharmaceuticals d.d. - sunitiniib - kõvakapsel - 12,5mg 30tk

Estonja - Estonjan - Ravimiamet

sandoz pharmaceuticals d.d. - sunitiniib - kõvakapsel - 37,5mg 84tk; 37,5mg 30tk; 37,5mg 56tk; 37,5mg 28tk

Unjoni Ewropea - Estonjan - EMA (European Medicines Agency)

accord healthcare s.l.u. - sunitiniib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastilised ained - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.

Estonja - Estonjan - Ravimiamet

teva b.v. - sunitiniib - kõvakapsel - 50mg 28tk; 50mg 30tk

Estonja - Estonjan - Ravimiamet

teva b.v. - sunitiniib - kõvakapsel - 12,5mg 30tk

Estonja - Estonjan - Ravimiamet

teva b.v. - sunitiniib - kõvakapsel - 25mg 28tk

Estonja - Estonjan - Ravimiamet

mylan ireland limited - sunitiniib - kõvakapsel - 12,5mg 30tk

Estonja - Estonjan - Ravimiamet

mylan ireland limited - sunitiniib - kõvakapsel - 50mg 28tk